Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosiglitazone in Glucose Intolerant Subjects
NCT00746174Phase 4Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- Feb 2004
- Primary completion
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rosiglitazone in impaired glucose tolerance (IGT), sponsored by UT Southwestern Medical Center. Started Feb 2004; status: completed.
02
Drugs
rosiglitazone
03
Conditions
impaired glucose tolerance (IGT)
Beyond the preview
Go deeper on NCT00746174.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00746174.